Quick Answer
Aurinia Pharmaceuticals Inc. reported Net Income of $287.20 million for fiscal year 2025.
Aurinia Pharmaceuticals Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $287.20M | +4893.1% |
| 2024 | $5.75M | +107.4% |
| 2023 | -$78.02M | +27.9% |
| 2022 | -$108.18M | +40.2% |
| 2021 | -$180.97M | -76.2% |
| 2020 | -$102.68M | -16.2% |
| 2019 | -$88.39M | -66.5% |
| 2018 | -$53.08M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.55M | +119.9% | +46.7% |
| June 30, 2025 | $21.51M | +2879.6% | -7.8% |
| March 31, 2025 | $23.34M | +317.2% | +62.7% |
| September 30, 2024 | $14.35M | +206.7% | +1887.5% |
| June 30, 2024 | $722.0K | +106.3% | +106.7% |
| March 31, 2024 | -$10.75M | +59.0% | +20.1% |
| September 30, 2023 | -$13.45M | -49.6% | -17.0% |
| June 30, 2023 | -$11.49M | +67.6% | +56.1% |
- Aurinia Pharmaceuticals Inc. showed an increase of +4893.1% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Aurinia Pharmaceuticals Inc.’s net income has grown by 641.1% (from -$53.08 million to $287.20 million).
- The most recent figure is from Aurinia Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: